Abstract
ABSTRACT: Synthetic pulmonary surfactants consisting of mixtures of phospholipids with synthetic peptides based on the amino acid sequence of human surfactant apoprotein SP-B were prepared. These surfactants were analyzed for their ability to lower surface tension on a pulsating bubble surfactometer and for their capacity to improve lung compliance and increase alveolar expansion in a fetal rabbit model of surfactant deficiency. The data demonstrate that several peptides, ranging from 17 to 45 residues in length, matching the carboxy-terminal sequence of the SP-B protein, when appropriately recombined with the phospholipids dipalmitoylphosphatidycholine and phosphatidylglycerol (3:1), are capable of producing a synthetic surfactant with biophysical and biologic activity approaching that of human surfactant derived from amniotic fluid.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Revak, S., Merritt, T., Hallman, M. et al. The Use of Synthetic Peptides in the Formation of Biophysically and Biologically Active Pulmonary Surfactants. Pediatr Res 29, 460–465 (1991). https://doi.org/10.1203/00006450-199105010-00010
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199105010-00010
This article is cited by
-
Effects of the lung surfactant protein B construct Mini-B on lipid bilayer order and topography
European Biophysics Journal (2012)
-
Perturbation of DPPC/POPG bilayers by the N-terminal helix of lung surfactant protein SP-B: a 2H NMR study
European Biophysics Journal (2009)